A carregar...

OUTCOMES FOLLOWING HCT USING FLUDARABINE, BUSULFAN AND THYMOGLOBULIN: A MATCHED COMPARISON TO ALLOGENEIC TRANSPLANTS CONDITIONED WITH BUSULFAN AND CYCLOPHOSPHAMIDE

We have reported a lower incidence of acute graft versus host disease (aGVHD) with a novel conditioning regimen using low dose rabbit anti-thymocyte globulin (TG, Thymoglobulin) with fludarabine and intravenous busulfan (FluBuTG). To assess further this single center experience, we performed a retro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bredeson, Christopher N., Zhang, Mei-Jie, Agovi, Manza-A., Bacigalupo, Andrea, Bahlis, Nizar J., Ballen, Karen, Brown, Christopher, Chaudhry, M. Ahsan, Horowitz, Mary M., Kurian, Seira, Quinlan, Diana, Muehlenbien, Catherine E., Russell, James A., Savoie, Lynn, Rizzo, J. Douglas, Stewart, Douglas A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321981/
https://ncbi.nlm.nih.gov/pubmed/18721762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.06.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!